KARABAY, A. Z. Et Al. 2017. Aspirin Inhibits Bcr-Abl and its Downstream Effectors in Chronic Myeloid Leukemia. VI. International Congress of Molecular Medicine , (İstanbul, Turkey), 55.

KARABAY, A. Z., KOÇ, A., Hekmatshoar, Y., KARADAĞ, A., & ÖZKAN, T., (2017). Aspirin Inhibits Bcr-Abl and its Downstream Effectors in Chronic Myeloid Leukemia . VI. International Congress of Molecular Medicine (pp.55). İstanbul, Turkey

KARABAY, ARZU Et Al. "Aspirin Inhibits Bcr-Abl and its Downstream Effectors in Chronic Myeloid Leukemia," VI. International Congress of Molecular Medicine, İstanbul, Turkey, 2017

KARABAY, ARZU Z. Et Al. "Aspirin Inhibits Bcr-Abl and its Downstream Effectors in Chronic Myeloid Leukemia." VI. International Congress of Molecular Medicine , İstanbul, Turkey, pp.55, 2017

KARABAY, A. Z. Et Al. (2017) . "Aspirin Inhibits Bcr-Abl and its Downstream Effectors in Chronic Myeloid Leukemia." VI. International Congress of Molecular Medicine , İstanbul, Turkey, p.55.

@conferencepaper{conferencepaper, author={ARZU ZEYNEP KARABAY Et Al. }, title={Aspirin Inhibits Bcr-Abl and its Downstream Effectors in Chronic Myeloid Leukemia}, congress name={VI. International Congress of Molecular Medicine}, city={İstanbul}, country={Turkey}, year={2017}, pages={55} }